Hence, the reprogramming of the suppressive tumor microenvironment would be achieved through the elimination of COX-1/2 enzymes, thereby mitigating the accumulation of their metabolite (PGE2) and subsequently attenuating immune suppressor cells. The gene discussed is PTGS1; the disease is neoplasm.